Introduction
============

Considering the increasing age of individuals affected with heart failure (HF), a specific approach to their treatment is required, with more attention being paid to geriatric conditions such as poor mobility, multiple disabilities, and cognitive impairment.[@b1-cia-10-1595],[@b2-cia-10-1595] Frailty syndrome (FS) is a distinct biological condition that reflects decreased physiological reserve and resistance to stressors. Frailty occurs more frequently among patients with HF than among the general population and serves as an independent predictor of visits to the emergency department, hospitalizations, and mortality.[@b1-cia-10-1595]--[@b3-cia-10-1595] It has shown to occur frequently in patients with HF, with prevalence ranging from 15% to 74%, depending on the studied population and the method of assessment. Elderly people constitute over 80% of the population of patients with HF.[@b4-cia-10-1595] The relationship between frailty and HF is complex and the two factors may exacerbate one another. Some studies have shown that frailty is independently associated with adverse outcomes in patients with HF including hospitalization and mortality.[@b1-cia-10-1595],[@b5-cia-10-1595],[@b6-cia-10-1595] Due to its prognostic role, the identification of frailty is of crucial importance in patients with HF. Additionally, the identification of individuals who are at an increased risk for frailty is important, as they may benefit from early therapeutic intervention. In this paper, we discuss the influence of frailty on health-related quality of life (HRQoL) results. Adverse outcomes of frailty may have a negative impact on HRQoL.

Gobbens et al[@b7-cia-10-1595] reported strong associations between Tilburg Frailty Indicator (TFI) scores (frailty) and quality of life (QoL), disability, and the presence of nursing and informal care. The prevalence of depression and anxiety is high in chronic patients with HF (10%--60% depression; 11%--45% anxiety); for this reason, we included these variables in the present study to determine if depression and anxiety might be correlated with FS and HRQoL.

Comorbid depression and anxiety are associated with increased mortality and health care utilization and have an impact on QoL. On average, patients with HF have much higher anxiety levels than healthy older adults.[@b8-cia-10-1595] Few researchers have reported that the presence of anxiety symptoms is an independent predictor of worsening functional status, poorer HRQoL and more frequent rehospitalizations.[@b9-cia-10-1595]--[@b11-cia-10-1595] Within the extensive literature on frailty, there has been little research on the impact of frailty on the HRQoL of patients with HF. This reflects a lack of knowledge about the special needs of patients with HF and FS. HRQoL has been defined as an individual's perception of their position in life in the context of the culture and value system in which they live, and in relation to their goals, expectations, standards, and concerns.[@b12-cia-10-1595] HRQoL is an important variable that may predict adverse outcomes in terms of how they predispose patients to progressing in functional and mental independence. Therefore, the purpose of this study was to assess the relationship between frailty, anxiety and depression, and the HRQoL of patients with HF. To our knowledge, this is the first study on this subject.

Patients and methods
====================

Study design
------------

Nurses administered the questionnaires used in the study. All patients gave their written informed consent for participation in the study. The inclusion criteria were age ≥60 years, diagnosis of HF, and written informed consent for participation in the study. The exclusion criteria were communication barriers (eg, deafness or blindness) or problems related to manual dexterity. Also, we excluded patients who had stroke, obturative pulmonary disease previously. The protocol for the study was approved by the Local Bioethical Committee of Wroclaw Medical University -- Nbr521/2014.

Frailty instrument
------------------

Frailty was measured using the TFI scale (Polish version).[@b13-cia-10-1595] TFI consists of two parts: one addresses the sociodemographic characteristics of a participant (sex, age, marital status, country of origin, educational level, and monthly income), as well as the potential determinants of frailty. The second part addresses the components of frailty. Part two of the TFI comprises 15 self-reported questions, divided into three domains. The physical domain (0--8 points) consists of eight questions related to physical health, unexplained weight loss, difficulty walking, balance, hearing problems, vision problems, strength in hands, and physical tiredness. The psychological domain (0--4 points) comprises four items related to cognition, depressive symptoms, anxiety, and coping. The social domain (0--3 points) comprises three questions related to living alone, social relations, and social support. Eleven items of part two of the TFI have two response categories (yes and no), while the other items have three (yes, no, and sometimes). "Yes" or "sometimes" responses were scored 1 point each, while "no" responses were scored 0. The instrument's total score ranged from 0 to 15: the higher the score, the higher one's frailty. Frailty was diagnosed when the total TFI score was 5. Previous research suggests that the TFI is a valid and reliable instrument for measuring frailty.[@b14-cia-10-1595]

QoL instrument
--------------

HRQoL was measured using the 36-Item Short Form Medical Outcomes Study Survey (SF-36) (Polish version).[@b15-cia-10-1595] The SF-36 measures the following eight generic health categories: physical functioning, role limitations due to physical problems, bodily pain, general perception of health, vitality, social functioning, role limitations due to emotional problems and mental health (MH). Subscale scores range from 0 to 100, with higher scores signifying greater HRQoL. The physical subscales, measuring physical problems, pain, and self-rated health constitute a PCS. The mental subscales, measuring daily functioning in relation to psychological issues and vitality, constitute a mental component scale (MCS).[@b15-cia-10-1595]

Psychological instrument for anxiety and depression
---------------------------------------------------

To determine the prevalence of anxiety and depression, we used the Hospital Anxiety and Depression Scale (HADS), which distinguishes itself from all other scales by its ability to assess anxiety and depression without investigating somatic symptoms. HADS is often used to analyze a variety of diseases in the clinical setting. The scale consists of a series of 14 questions, seven of which are related to anxiety (HAD-A), while the other seven questions are related to depression (HAD-D). The creators of the scale considered a score of less than 8 to indicate the lack of any mental disorder, a score equal to or greater than 8 to indicate that a disorder was "probably" present, while a score greater than 10 was considered to indicate that a patient was "highly likely" to have a disorder.[@b16-cia-10-1595],[@b17-cia-10-1595]

Participants
------------

The study included 100 patients (53 men and 47 women) with a diagnosis of HF. All of the participants agreed to participate in the project and answered all the questions included in the questionnaires that were administrated.

Statistical analysis
--------------------

Statistical analyses were performed using the Statistica v10 package (StatSoft, Tulsa, OK, USA). Descriptive statistics were presented by nonfrail and frail patients, and differences between groups were assessed via Mann--Whitney *U* test or Student's *t*-test for independent samples and Pearson's chi-square tests or Fisher's exact tests for independence. Differences in mean scores on the SF-36 subscales by frailty status were also identified using a Mann--Whitney *U* test. Multivariable models testing the effect of frailty status on the SF-36 summary scores were developed using multivariate linear regression analyses. In addition, to test the effect of frailty on each subscale of SF-36, we used stepwise multivariate linear regression analyses to measure the *R*^2^ change of frailty.

Results
=======

The study included 100 consecutive patients (mean age: nonfrail, 62.3±6.2 years; frail, 67.9±10.7 years). The majority of our participants were unmarried (widowed or divorced) (n=64) ([Table 1](#t1-cia-10-1595){ref-type="table"}) and included 53 men and 47 women. All of the participants agreed to participate in the project and answered all the questions included in the questionnaires that were administrated.

Frailty was found in 89% of the studied population. The average results of TFI in the group with FS were 8.4±2.4, and in nonfrail patients with TFI values of 3.2±0.9 (*P*\<0.001). The average value of HADS-anxiety in the group with FS was 9.5±4.5. In the group of nonfrail 3.9±3.3 (*P*\<0.001). The average value of the HADS-depression in the group with FS was 8.8±4.9 and in the nonfrail group was 3.4±2.8 (*P*\<0.001) ([Table 1](#t1-cia-10-1595){ref-type="table"}).

The HRQoL results for PCS in frail group were: 67.0±19.5, nonfrail: 52.4±19.5 (*P*\<0.001). The HRQoL results in MCS in frail group were: 42.9±16.6, nonfrail: 52.4±19.5 (*P*\<0.001) ([Table 1](#t1-cia-10-1595){ref-type="table"}).

The study showed significant inverse correlations between the values of the PCS domain results and TFI score (*r*=−0.66, *P*\<0.001) ([Table 2](#t2-cia-10-1595){ref-type="table"}) and significantly inverse correlation between values of the MCS domain and TFI score (*r*=−0.68, *P*\<0.001) ([Table 2](#t2-cia-10-1595){ref-type="table"}). With an increase in the value of TFI, the QoL among patients with HF deteriorated. Our analysis showed significant positive correlations between TFI scores, HADS-anxiety results (*r*=0.60, *P*\<0.001), and HADS-depression results (*r*=0.66, *P*\<0.001).

We found that a higher TFI score is a strong predictor of worsening PCS and MCS results ([Table 2](#t2-cia-10-1595){ref-type="table"}). When the participants showed increased levels of frailty measured by the TFI scale, there was also an increase in the level of anxiety and depression.

Our analysis showed a significant inverse correlation between PCS domain values and the values of HADS-anxiety (*r*=−0.51) and HADS-depression (*r*=−0.61, *P*\<0.001; [Table 2](#t2-cia-10-1595){ref-type="table"}). There was also a significant inverse correlation between MCS domain values and the values of HADS-anxiety (*r*=−0.59) and HADS-depression (*r*=−0.74, *P*\<0.001) ([Table 2](#t2-cia-10-1595){ref-type="table"}). An increase in anxiety and depression showed deterioration in the QoL in patients with HF.

Multiple regression analyses showed that the parameters that exerted a significant independent effect on the level of the PCS scores were those derived from the results of the TFI questionnaire ([Table 3](#t3-cia-10-1595){ref-type="table"}). Multiple regression analyses showed that the parameters that exerted a significant independent effect on the level of the MCS scale scores were the TFI and the HADS-depression results ([Table 4](#t4-cia-10-1595){ref-type="table"}). Multiple regression analyses showed that the parameters that exerted a significant independent effect on the level of the TFI were age \>65 years PCS score and HADS-anxiety ([Table 5](#t5-cia-10-1595){ref-type="table"}).

In the regression analysis, higher HADS results were predictive of frailty. Additionally, older age was a predictor of higher results in the TFI score. Lower TFI scores correlated with higher PCS results. Other sociodemographic variables had no impact on the results.

Discussion
==========

The purpose of this study was to assess the relationship between frailty, and anxiety and depression on the one hand, and HRQoL on the other, in patients with HF. The instrument we used to assess frailty (TFI) is based on the definition of "frailty" as a dynamic state affecting an individual who experiences losses in one or more domains of human functioning (physical, psychological, and social), which are caused by the influence of a range of variables and which increases the risk of adverse outcomes.[@b18-cia-10-1595] Several studies have documented an association between the FS and cardiovascular disease. This relationship is particularly strong in the case of HF,[@b19-cia-10-1595]--[@b21-cia-10-1595] ranging from 15% to 74%.

HF adversely affects the patients' lives, severely restricting them in many areas of activity and social functioning, which lowers their QoL.[@b22-cia-10-1595],[@b23-cia-10-1595]

Depression increases the frequency of rehospitalization in patients with HF, according to Johnson et al[@b24-cia-10-1595] by a factor of 1.5 compared to patients with HF without depression. This remains true even when cooperation between the physician and the patient is good, and the patient takes medication regularly. Patients with HF often experience symptoms of depression and cognitive disorders, which interfere with compliance with treatment and lower the QoL. The authors report that depressed patients are not as careful as nondepressed patients when it comes to medication,[@b25-cia-10-1595] and they do not take medication as commonly as those who are not depressed (75% vs 21%, *P*\<0.01).[@b26-cia-10-1595] We found that being frail was significantly correlated with lower scores in perception in the MCS, PCS and lower scores in the SF-36, when compared to patients who were not frail ([Tables 3](#t3-cia-10-1595){ref-type="table"} and [4](#t4-cia-10-1595){ref-type="table"}). Low scores on the MCS and PCS were also associated with a higher score in depression and anxiety. Other authors report that the deteriorating health of patients with HF makes them realize the possibility of death, which leads to depression, anxiety, and sleep disorders, that is, a further deterioration of psychosocial health.[@b27-cia-10-1595]

Implications for practice
-------------------------

Little is known about the relationship between frailty status and the different aspects of QoL in general, as well as on the interventions for improving QoL in frail patients with HF. We believe that it is of great importance to pay special attention to the distinctive needs of frailty patients in the context of HF to improve functional and mental independence, as well as QoL. Implementation of the early detection of frailty within this group remains an issue of paramount importance, as this approach may prevent functional decline and improve or maintain the individual's independence.

Study limitations
-----------------

We are well aware of the potential limitations of this study. The most important of these stem from the fact that our study sample was relatively small and recruited from a single center. Additionally, most of the patients were frail (89%). We plan to extend our research on this subject in the future.

Conclusion
==========

Frailty has a negative impact on the HRQoL results of elderly patients with HF. The assessment of FS and anxiety and depression should be taken into account when estimating risk and making therapeutic decisions for cardiovascular disease treatment and care.
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###### 

Sociodemographic and clinical characteristics of patients by frailty status

  Variable                                              Patients      *P*-value     
  ----------------------------------------------------- ------------- ------------- --------------------------------------------------------
  Age (years), mean (SD)                                62.3 (6.2)    67.9 (10.7)   0.090[a](#tfn1-cia-10-1595){ref-type="table-fn"}
  Sex                                                                               0.142[b](#tfn2-cia-10-1595){ref-type="table-fn"}
   Male (n=53)                                          8 (72.7%)     45 (50.6%)    
   Female (n=47)                                        3 (27.3%)     44 (49.4%)    
  Years of education, mean (SD)                         11.2 (1.3)    11.5 (2.3)    0.674[a](#tfn1-cia-10-1595){ref-type="table-fn"}
  Civil status                                                                      0.166[b](#tfn2-cia-10-1595){ref-type="table-fn"}
   Married (n=36)                                       2 (18.2%)     34 (38.2%)    
   Unmarried (n=64)                                     9 (81.8%)     55 (61.8%)    
  Number of hospitalizations during 1 year, mean (SD)   1.4 (0.5)     1.8 (1.1)     0.150[a](#tfn1-cia-10-1595){ref-type="table-fn"}
  Time from HF diagnosis (years), mean (SD)             7.7 (4.2)     9.8 (6.0)     0.352[d](#tfn4-cia-10-1595){ref-type="table-fn"}
  Income (PLZ)                                                                      0.826[c](#tfn3-cia-10-1595){ref-type="table-fn"}
   \<3,000 zł (n=97)                                    11 (100.0%)   86 (96.6%)    
   3,000--5,000 zł (n=2)                                0 (0.0%)      2 (2.3%)      
   \>5,000 zł (n=1)                                     0 (0.0%)      1 (1.1%)      
  NYHA class                                                                        0.233[c](#tfn3-cia-10-1595){ref-type="table-fn"}
   I (n=10)                                             3 (27.3%)     7 (7.9%)      
   II (n=53)                                            5 (45.4%)     48 (53.9%)    
   III (n=35)                                           3 (27.3%)     32 (36.0%)    
   IV (n=2)                                             0 (0.0%)      2 (2.2%)      
  Medication                                                                        
   Diuretics (n=84)                                     9 (81.8%)     75 (84.3%)    0.557[b](#tfn2-cia-10-1595){ref-type="table-fn"}
   Beta-blockers (n=87)                                 11 (100%)     76 (85.4%)    0.198[b](#tfn2-cia-10-1595){ref-type="table-fn"}
   ACE/ARB (n=64)                                       6 (54.6%)     58 (65.2%)    0.352[b](#tfn2-cia-10-1595){ref-type="table-fn"}
   Digoxin (n=13)                                       1 (9.1%)      12 (13.5%)    0.565[b](#tfn2-cia-10-1595){ref-type="table-fn"}
  HADS                                                                              
   Anxiety, mean (SD)                                   3.9 (3.3)     9.5 (4.5)     
   Depression, mean (SD)                                3.4 (2.8)     8.8 (4.9)     **0.001**[d](#tfn4-cia-10-1595){ref-type="table-fn"}
  SF-36                                                                             
   PCS, mean (SD)                                       52.4 (19.5)   32.8 (17.0)   **0.001**[a](#tfn1-cia-10-1595){ref-type="table-fn"}
   MCS, mean (SD)                                       67.0 (17.9)   42.9 (16.6)   \<**0.001**[a](#tfn1-cia-10-1595){ref-type="table-fn"}
  TFI score, mean (SD)                                  3.2 (0.9)     8.4 (2.4)     \<**0.001**[a](#tfn1-cia-10-1595){ref-type="table-fn"}

**Notes:**

*t*-test;

Fisher's exact test;

Pearson's chi-square;

Mann--Whitney *U* test. Data in bold indicates statistical significance.

**Abbreviations:** HF, heart failure; PLZ, Polish zloty; NYHA, New York Heart Association; SF-36, Short Form 36; HADS, Hospital Anxiety and Depression Scale; MCS, mental component scale; PCS, physical component scale; TFI, Tilburg Frailty Indicator; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker.

###### 

Correlations between frailty, anxiety and depression, and health-related quality of life (n=100)

  Variable          SF-36 PCS                                               SF-36 MCS                                               HADS-anxiety                                            HADS-depression
  ----------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------
  TFI score         −0.66[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}   −0.68[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}   0.60[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}    0.66[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}
  SF-36 total       0.92[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}    0.94[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}    −0.60[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}   −0.73[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}
  SF-36 PCS                                                                 0.75[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}    −0.51[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}   −0.61[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}
  SF-36 MCS                                                                                                                         −0.59[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}   −0.74[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}
  HADS-anxiety                                                                                                                                                                              0.73[\*\*\*](#tfn6-cia-10-1595){ref-type="table-fn"}
  HADS-depression                                                                                                                                                                           

**Notes:**

*P*\<0.001.

**Abbreviations:** TFI, Tilburg Frailty Indicator; PCS, physical component scale; MCS, mental component scale; SF-36, Short Form 36; HADS, Hospital Anxiety and Depression Scale.

###### 

Regression summary for dependent variable: SF-36 PCS

                    Beta     SE of Beta   B SE of B     *t*(97) *P*-value
  ----------------- -------- ------------ ------------- -------------------
  Intercept                               64.8 4.2      15.484 \<0.001
  TFI score         −0.392   0.101        −2.57 0.662   −3.886 \<0.001
  HADS-depression   −0.328   0.101        −1.19 0.366   −3.250 0.002

**Notes:** *R*=0.655, *R*^2^=0.429, adjusted *R*^2^=0.417, *F*(2.97)=6.4, *P*\<0.00001.

**Abbreviations:** SE, standard error; TFI, Tilburg Frailty Indicator; HADS, Hospital Anxiety and Depression Scale; SF, Short Form 36; PCS, physical component scale.

###### 

Regression summary for dependent variable: SF-36 MCS

                    Beta     SE of Beta   B SE of B     *t*(97) *P*-value
  ----------------- -------- ------------ ------------- -------------------
  Intercept                               78.1 3.6      21.811 \<0.001
  TFI score         −0.348   0.086        −2.29 0.566   −4.044 \<0.001
  HADS-depression   −0.492   0.086        −1.79 0.313   −5.729 \<0.001

**Notes:** *R*=0.765, *R*^2^=0.586, adjusted *R*^2^=0.577, *F*(2.97)=68.5, *P*\<0.00001.

**Abbreviations:** SE, standard error; TFI, Tilburg Frailty Indicator; HADS, Hospital Anxiety and Depression Scale; SF, Short Form 36; MCS, mental component scale.

###### 

Regression summary for dependent variable: TFI score

                 Beta     SE of Beta   B       SE of B   *t*(96)   *P*-value
  -------------- -------- ------------ ------- --------- --------- -----------
  Intercept                            3.20    1.70      1.899     0.061
  Age            0.280    0.070        0.08    0.02      4.188     \<0.001
  PCS score      −0.385   0.083        −0.06   0.01      −4.639    \<0.001
  HADS-anxiety   0.384    0.080        0.23    0.05      4.775     \<0.001

**Notes:** *R*=0.776, *R*^2^=0.602, adjusted *R*^2^=0.590, *F*(3.96)=48.4, *P*\<0.00001.

**Abbreviations:** TFI, Tilburg Frailty Indicator; SE, standard error; PCS, physical component scale; HADS, Hospital Anxiety and Depression Scale.
